Public Company News

Mabwell Bioscience and Aditum Bio Announce Formation of Kalexo Bio to Advance Innovative siRNA Therapy for Cardiovascular Disorders

SHANGHAI and OAKLAND, Calif., Sept. 17, 2025 /PRNewswire/ -- Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SH) and Aditum Bio today announced the launch of Kalexo Bio, a new company formed in conjunction with an exclusive global license agreement to develop2MW7141, a novel dual-target siRNA cand...

2025-09-17 20:00 2218

OPPENHEIMER EXPANDS GLOBAL CREDIT TEAM

New European team enhances global client coverage and collaboration, with a focus on global high yield and distressed assets LONDON, Sept. 17, 2025 /PRNewswire/ -- Oppenheimer Europe Limited (Oppenheimer) – a subsidiary of Oppenheimer Holdings, a leading investment bank and wealth manager (NYSE:...

2025-09-17 17:00 4784

Alteogen Receives European Commission Approval for Aflibercept Biosimilar, EYLUXVI® (ALT-L9)

* EYLUXVI® is the second biosimilar approved for Alteogen following the launch of the Herceptin® biosimilar in China through its partner Qilu Pharmaceutical. DAEJEON, South Korea, Sept. 17, 2025 /PRNewswire/ -- Alteogen Inc. (KOSDAQ:196170) announced today that the European Commission (EC) has ...

2025-09-17 15:40 4363

Adyen, Partner of LVMH, Redefines Payments in the Global Luxury Sector

PARIS, Sept. 17, 2025 /PRNewswire/ -- Adyen , the global financial technology platform for leading businesses, is supporting LVMH, the world leader in luxury goods, in a major internati...

2025-09-17 15:05 4534

Sun Life and Beyond Sport's "Hoops + Health" program empowers more than 48,000 young people across Asia to get active

Building on last year's success, the program scaled up in its second year to inspire healthier lifestyles through basketball, with a 250% surge in participation HONG KONG, Sept. 17, 2025 /PRNewswire/ -- Sun Life, in partnership with global sport for social change foundation Beyond Sport, has suc...

2025-09-17 14:28 3381

111, Inc. Announces Second Quarter 2025 Unaudited Financial Results

* Maintained Quarterly Operational Profitability * Operating Expenses as a Percentage of Revenues Decreased 20 Basis Points YoY * Maintained Positive Operating Cash Flow in the First Half of the Year SHANGHAI, Sept. 17, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a l...

2025-09-17 14:00 5338

Shipsy Partners with Tech Mahindra to Expedite Logistics Transformation by Building an AI-Native Supply Chain Ecosystem

LONDON, Sept. 17, 2025 /PRNewswire/ -- Shipsy , a Gartner recognized leading global AI-native transportation management platform provider, andTech Mahindra (NSE: TECHM), a leading global provider of technology consulting and digital solutions to...

2025-09-17 13:49 3390

Results of Annual General Meeting of Shareholders

MONTREAL, Sept. 17, 2025 /PRNewswire/ -- September 17, 2025 – Sydney, Australia Patriot Battery Metals Inc. (the "Company") (TSX: PMET) (ASX: PMT) (OTCQX: PMETF) (FSE: R9GA) is pleased to announce results of voting at its Annual General Shareholder Meeting held onTuesday, September 16, 2025, at 8...

2025-09-17 12:43 2457

DXC Launches Global AI Center of Competence to Accelerate Enterprise AI Adoption

ASHBURN, Va., Sept. 17, 2025 /PRNewswire/ -- DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, today announced the launch of a new AI Center of Competence inWarsaw, Poland, which joins a growing network of DXC AI centers globally.

2025-09-17 12:01 5206

Three WuXi Biologics Manufacturing Facilities Receive GMP Certification from Türkiye İlaç ve Tıbbi Cihaz Kurumu (TITCK)

WUXI, China, Sept. 17, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that three of its manufacturing facilities in Wuxi – MFG1, MFG2, and DP5 – have received GMP certification from Türkiye İlaç ve ...

2025-09-17 12:00 2442

Kexing Biopharm's Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Registered with FDA DMF

SHENZHEN, China, Sept. 16, 2025 /PRNewswire/ -- Kexing Biopharm announced that its investigational Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes has successfully completed a Type II Drug Master File (DMF) registration with the U.S. FDA. Exosomes, as a next-generation bioactive carr...

2025-09-17 10:30 3935

Osaka Rises as the Top Choice for Chinese Travelers Celebrating Golden Week, Agoda Reports

SINGAPORE, Sept. 17, 2025 /PRNewswire/ -- Digital travel platform Agoda reveals a rise in travel interest among Chinese travelers during Golden Week, with a 26% increase in interest for both domestic and international journeys based on travel searches. Celebrated fromOctober 1st to 8th, Golden We...

2025-09-17 10:10 1972

T'way Air Connects Hong Kong Travelers to Korea's Autumn Festivals

Special Promo Code and Bonus Coupons for Hong Kong–Incheon Flights Until September 30 HONG KONG, Sept. 17, 2025 /PRNewswire/ -- T'way Air, Korea's leading low-cost carrier, invites travelers to enjoy special savings on its Hong Kong–Incheon ( Seoul) flights through its "Weekend Getaway Deals", av...

2025-09-17 09:00 4012

Discover Korea's Golden Autumn: T'way Air's Seasonal Deals from Singapore

Special Promo Code and Coupons Available for Singapore–Incheon and Singapore–Jeju Flights SINGAPORE, Sept. 17, 2025 /PRNewswire/ -- T'way Air, Korea's leading low-cost carrier, invites travelers to enjoy special savings through its "Golden Autumn Deal" until September 30, for bookings on Singapo...

2025-09-17 09:00 2793

Tapping Into the Trillion-Dollar Healthcare Market: Home Control(1747.HK) will Establish Hong Kong Subsidiary and Build a Global Health Services Ecosystem

HONG KONG, Sept. 17, 2025 /PRNewswire/ -- Home Control (1747.HK), one of the most closely watched small-cap names on theHong Kong market this year, has once again caught investors' attention. After a tenfold rally in the first half of 2025, the Company has unveiled a series of bold strategic move...

2025-09-17 08:00 4143

Ascletis Presented Results from Cohorts 1 and 2 of 28-day Multiple Ascending Dose Study of Its Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting

-          ASC30 once-daily oral tablet demonstrated up to 6.5% placebo-adjusted mean body weight reduction from baseline after 28-day treatment. -          ASC30 tablet's higher efficacy is supported by its higher oral drug exposures. -          ASC30 is safe and well tolerated with only mild-...

2025-09-17 07:30 2231

LEVOIT AND BEST FRIENDS ANIMAL SOCIETY LAUNCH "PROTECT THEIR SANCTUARY" CAMPAIGN TO PROMOTE WELLNESS FOR PETS AND PEOPLE, SUPPORT NO-KILL EFFORTS

Home wellness brand pledges $100,000 and donates products to Best Friends, supporting healthier, pet-friendly homes and lifesaving programs for pets TUSTIN, Calif., Sept. 16, 2025 /PRNewswire/ -- Levoit™ , VeSync's premier smart home brand dedicated to home wellness, has...

2025-09-17 00:00 2805

Cyient Semiconductors & Anora Partner to Expand Turnkey Test and Validation Solutions

HYDERABAD, India, Sept. 16, 2025 /PRNewswire/ -- Cyient Semiconductors, a leader in custom ASIC/ASSP and intelligent power solutions, announced a strategic partnership with Anora, a global provider of semiconductor test, testability, and validation services. The collaboration brings together com...

2025-09-16 22:30 1883

Minesto presents today at Aktiedagarna i Stockholm

GOTHENBURG, Sweden, Sept. 16, 2025 /PRNewswire/ -- Minesto's CEO Dr Martin Edlund presents today at Aktiedagarna iStockholm by Aktiespararna, 16 September 2025   The event is livestreamed, and Minesto will be presenting at 15.10 CEST:  Aktiedagarna i Stockholm | Aktiespararna

2025-09-16 21:49 1617

Lunit Showcases AI-Powered Cancer Ecosystem at APEC High-Level Meeting on Health and the Economy and World Bio Summit 2025

Lunit highlights global leadership in cancer AI alongside world health experts with dedicated APEC HLMHE session and WBS 2025 Leaders' Dialogue SEOUL, South Korea, Sept. 16, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announc...

2025-09-16 21:00 5714